HIV outbreaks among people who inject drugs in Europe, North America, and Israel.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

During 2011-16, HIV outbreaks occurred among people who inject drugs (PWID) in Canada (southeastern Saskatchewan), Greece (Athens), Ireland (Dublin), Israel (Tel Aviv), Luxembourg, Romania (Bucharest), Scotland (Glasgow), and USA (Scott County, Indiana). Factors common to many of these outbreaks included community economic problems, homelessness, and changes in drug injection patterns. The outbreaks differed in size (from under 100 to over 1000 newly reported HIV cases among PWID) and in the extent to which combined prevention had been implemented before, during, and after the outbreaks. Countries need to ensure high coverage of HIV prevention services and coverage higher than the current UNAIDS recommendation might be needed in areas in which short acting drugs are injected. In addition, monitoring of PWID with special attention for changing drug use patterns, risk behaviours, and susceptible subgroups (eg, PWID experiencing homelessness) needs to be in place to prevent or rapidly detect and contain new HIV outbreaks.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Lancet HIV

Title: The lancet. HIV

Publisher: Elsevier BV

ISSN (Electronic): 2352-3018

ISSN (Print): 2352-3018

Publication date (Electronic): June 2020

Volume: 7

Issue: 6

Affiliations

[1 ] College of Global Public Health, New York University, New York, NY, USA. Electronic address: don.desjarlais@nyu.edu.

[2 ] Department of Hygiene, Epidemiology and Medical Statistics, National and Kapodistrian University of Athens, Athens, Greece.

[3 ] College of Global Public Health, New York University, New York, NY, USA.

[4 ] National Institute for Infectious Diseases, Bucharest, Romania.

[5 ] Service National des Maladies Infectieuses, Centre Hospitalier de Luxembourg, Luxembourg, USA.

[6 ] Centers for Disease Control and Prevention, Atlanta, GA, USA.

[7 ] Department of Tuberculosis and AIDS, Ministry of Health, Jerusalem, Israel; Faculty of Medicine, Hebrew University-Hadassah Medical School, Braun School of Public Health and Community Medicine, Jerusalem, Israel.

[8 ] Department of Infection and Immunity, Luxembourg Institute of Health, Esch sur Alzette, Luxembourg.

[9 ] Richard M Fairbanks School of Public Health, Indianapolis, IN, USA.

[10 ] Health Services Executive, Dublin, Ireland.

[11 ] NHS National Services Scotland, Glasgow, UK.

[12 ] Department of Hygiene, Epidemiology and Medical Statistics, National and Kapodistrian University of Athens, Athens, Greece; NHS National Services Scotland, Glasgow, UK.

[13 ] Infectious Diseases Unit, Tel Aviv Sourasky Medical Centre and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

[14 ] First Nations and Inuit Health Branch, Indigenous Services Canada, Regina, SK, Canada.

[15 ] NHS National Services Scotland, Glasgow, UK; School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.

[16 ] College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.

[17 ] European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.

Article

Publisher Item ID: S2352-3018(20)30082-5

DOI: 10.1016/S2352-3018(20)30082-5

PubMed ID: 32504576

SO-VID: f802336e-ff49-494e-b008-0e4413dbf775

History

Data availability:

Comments

Comment on this article

scite_

Cited by 29

See all cited by